Indivior shares gain on FDA addiction ruling
By Bloomberg | Published Nov 2, 2017
Indivior shares surged the most in three months after an FDA panel backed the company?s treatment for addiction to opioids.
By Bloomberg | Published Nov 2, 2017
Indivior shares surged the most in three months after an FDA panel backed the company?s treatment for addiction to opioids.
By Reuters | Published Nov 2, 2017
Fundsmith said it was launching a fund to tap growing demand from institutional clients in sustainable investment.
By Ole Petter Skonnord | Published Nov 2, 2017
By Mel Frykberg | Published Nov 2, 2017
By Reuters | Published Nov 1, 2017
By Thembelihle Mkhonza | Published Nov 1, 2017
By Tanisha Heiberg | Published Oct 31, 2017
By Amelia Morgenrood | Published Oct 30, 2017
By Siseko Njobeni | Published Oct 27, 2017
By Bloomberg | Published Oct 26, 2017
By Staff Reporter | Published Oct 25, 2017
By Reuters | Published Oct 25, 2017
By Bloomberg | Published Oct 24, 2017
By Jemima Kelly And Maiya Keidan | Published Oct 23, 2017
By Thembelihle Mkhonza | Published Oct 19, 2017
By Ryk de Klerk | Published Oct 19, 2017